Related Experiment Video
Updated: Oct 25, 2025

07:35
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
1.9K
A Multimodal Framework for Improving in Silico Drug Repositioning With the Prior Knowledge From Knowledge Graphs
Summary
GraphPK enhances drug repositioning by integrating knowledge graphs, known associations, and biological data. This multimodal framework improves prediction accuracy for novel drug-disease treatments.
Area of Science:
- Computational biology
- Pharmacology
- Bioinformatics
Background:
- Drug repositioning is crucial for discovering new disease treatments.
- Large biological datasets aid drug repositioning, but efficient utilization is challenging.
- Integrating diverse data sources is key to improving in silico drug repositioning.
Purpose of the Study:
- To develop a novel multimodal framework, GraphPK, for enhanced in silico drug repositioning.
- To leverage prior knowledge from drug knowledge graphs and biological data.
- To improve the prediction of drug-disease associations.
Main Methods:
- Constructed a knowledge graph integrating drugs, diseases, and their associations.
- Applied knowledge graph embedding to extract drug and disease prior knowledge.
- Utilized known drug-disease associations and biological domain features (chemical structures, semantic similarity).
- Designed a multimodal neural network to combine diverse features for prediction.
Main Results:
- GraphPK significantly outperforms state-of-the-art methods in predicting drug-disease associations.
- Ablation studies confirm the critical role of knowledge graph prior knowledge in predictive power and robustness.
- Case studies suggest GraphPK's potential for practical application in drug discovery.
Conclusions:
- GraphPK offers a robust and effective approach for in silico drug repositioning.
- Integrating prior knowledge from knowledge graphs substantially enhances prediction accuracy.
- The multimodal framework demonstrates potential for real-world drug discovery applications.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
9.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.7K
Structure-Activity Relationships and Drug Design
1.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K
Bioequivalence of Drugs: Drugs with Multiple Indications
28
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
28
Targets for Drug Action: Overview
8.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
8.2K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
149
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
149
Quantitative Aspects of Drug-Receptor Interaction
1.4K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.4K

